Synergistically, these perturbations activate NF-κB/STAT3 signaling, generating a pro-inflammatory cytokine milieu (IL-6, TNF-α, IL-1β) that promotes tumor progression through autocrine-paracrine cascades. The gene discussed is NFKB1; the disease is neoplasm.